These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5037838)

  • 1. [Effect of 3,4-dihydroxyphenylalanine (levodopa) in hepatic coma].
    González-Posada J; Hernández-Peniche J; Tirado-Arroyave S
    Arch Invest Med (Mex); 1972; 3(1):1-6. PubMed ID: 5037838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Levodopa treatment in hepatic coma (with special consideration of serial EEG changes (author's transl)].
    Lanzinger G; Kommerell B
    Dtsch Med Wochenschr; 1974 Apr; 99(14):700-5. PubMed ID: 4835344
    [No Abstract]   [Full Text] [Related]  

  • 3. [Presentation of a female patient with hepatic coma cured by treatment with L-Dopa].
    Sarrazin A; Emerit J; Olivier L; Rebelo R; Bousquet O
    Rev Neurol (Paris); 1971 Nov; 125(5):391-3. PubMed ID: 5153293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of L-dopa on hepatic coma].
    Jorge AD; Sanchez D
    Schweiz Rundsch Med Prax; 1973 Jul; 62(27):868-72. PubMed ID: 4578027
    [No Abstract]   [Full Text] [Related]  

  • 5. Levodopa in hepatic coma.
    Parkes JD; Sharpstone P; Williams R
    Lancet; 1970 Dec; 2(7687):1341-3. PubMed ID: 4098911
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatic coma. Treatment with L-dopa. Preliminary report].
    Hernández Peniche J; González Posada JC; Tirado Arroyave S
    Prensa Med Mex; 1972; 37(5):161-2. PubMed ID: 5069454
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of L-Dopa in the treatment of hepatic coma. Comments and personal contributions].
    Ossorio Castellanos C; Noguera Hernando E; Isasía Muñoz T; Aboy Martin A; Seoane J
    Rev Esp Enferm Apar Dig; 1974 Jun; 43(5):563-72. PubMed ID: 4850088
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hepatic coma with L-dopa. Preliminary results].
    Sarrazin A; Emerit J; Olivier L; Rebelo F; Bousquet O
    Presse Med (1893); 1971 Nov; 79(49):2226-7. PubMed ID: 5156758
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa.
    Abramsky O; Goldschmidt Z
    Surgery; 1974 Feb; 75(2):188-91. PubMed ID: 4544184
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
    Girard PF; Trillet M; Kopp N
    Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744
    [No Abstract]   [Full Text] [Related]  

  • 12. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatic encephalopathy with levodopa.
    Lunzer M; James IM; Weinman J; Sherlock S
    Gut; 1974 Jul; 15(7):555-61. PubMed ID: 4430473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa in the treatment of hepatic coma due to fulminant hepatic failure.
    Mehta JM; Karamarkar SG; Pimparkar BD; Sheth UK
    J Postgrad Med; 1976 Jan; 22(1):32-6. PubMed ID: 966185
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Criteria for intensive treatment of hepatic coma].
    Ruffo A; Motta G
    Minerva Med; 1976 Mar; 67(14):861-79. PubMed ID: 944403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

  • 19. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 20. Parenteral application of a special amino acid solution in the treatment of severe hepatic encephalopathy.
    Reiter HJ; Bode JC
    Z Gastroenterol; 1978 Jul; 16(7):457-64. PubMed ID: 685343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.